# Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF

> **NCT00156780** · PHASE1 · COMPLETED · sponsor: **Acusphere**

## Conditions studied

- Congestive Heart Failure
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** AI-700

## Key facts

- **NCT ID:** NCT00156780
- **Lead sponsor:** Acusphere
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** — (—)
- **Last updated:** 2006-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156780, "Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00156780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*